GetTopicDetailResponse(id=967c1911e16, topicName=α-1抗胰蛋白酶, introduction=α-1抗胰蛋白酶, content=null, image=null, comments=5, allHits=1181, url=https://h5.medsci.cn/topic?id=19117, type=1, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=71874, tagList=[TagDto(tagId=71874, tagName=α-1抗胰蛋白酶)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1956417, encodeId=9e67195641eaa, content=<a href='/topic/show?id=967c1911e16' target=_blank style='color:#2F92EE;'>#α-1抗胰蛋白酶#</a>, objectTitle=《新英格蘭醫(yī)學(xué)雜志》發(fā)表Fazirsiran治療α-1抗胰蛋白酶缺乏癥患者的二期研究結(jié)果, objectType=article, longId=730850, objectId=e34ae3085081, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e34ae3085081, replyNumber=0, likeNumber=104, createdTime=2023-04-28, rootId=0, userName=ms7514935887898259, userId=78d82500042, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e34ae3085081, moduleTitle=《新英格蘭醫(yī)學(xué)雜志》發(fā)表Fazirsiran治療α-1抗胰蛋白酶缺乏癥患者的二期研究結(jié)果, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=e34ae3085081)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956416, encodeId=3efe195641689, content=<a href='/topic/show?id=967c1911e16' target=_blank style='color:#2F92EE;'>#α-1抗胰蛋白酶#</a>, objectTitle=日本厚生勞動(dòng)省（MHLW）批準(zhǔn)α-1蛋白酶抑制劑Lynspad治療α-1抗胰蛋白酶缺乏癥, objectType=article, longId=206186, objectId=022b2061861a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=022b2061861a, replyNumber=0, likeNumber=236, createdTime=2021-06-04, rootId=0, userName=ms7514935887898259, userId=78d82500042, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=022b2061861a, moduleTitle=日本厚生勞動(dòng)省（MHLW）批準(zhǔn)α-1蛋白酶抑制劑Lynspad治療α-1抗胰蛋白酶缺乏癥, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=022b2061861a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956415, encodeId=de8219564155c, content=<a href='/topic/show?id=967c1911e16' target=_blank style='color:#2F92EE;'>#α-1抗胰蛋白酶#</a>, objectTitle=α-1抗胰蛋白酶（A1AT）缺乏癥治療或取得重大突破：DCR-A1AT獲得孤兒藥認(rèn)定, objectType=article, longId=190435, objectId=1500190435a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1500190435a1, replyNumber=0, likeNumber=95, createdTime=2020-07-24, rootId=0, userName=ms7514935887898259, userId=78d82500042, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1500190435a1, moduleTitle=α-1抗胰蛋白酶（A1AT）缺乏癥治療或取得重大突破：DCR-A1AT獲得孤兒藥認(rèn)定, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=1500190435a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956414, encodeId=5f9a1956414fe, content=<a href='/topic/show?id=967c1911e16' target=_blank style='color:#2F92EE;'>#α-1抗胰蛋白酶#</a>, objectTitle=J Hepatology： α-1抗胰蛋白酶缺乏癥在非肝硬化隊(duì)列中的臨床和組織學(xué)特征, objectType=article, longId=154410, objectId=1a8f15441020, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1a8f15441020, replyNumber=0, likeNumber=76, createdTime=2019-05-20, rootId=0, userName=ms7514935887898259, userId=78d82500042, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1a8f15441020, moduleTitle=J Hepatology： α-1抗胰蛋白酶缺乏癥在非肝硬化隊(duì)列中的臨床和組織學(xué)特征, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=1a8f15441020)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1956413, encodeId=722119564139f, content=<a href='/topic/show?id=967c1911e16' target=_blank style='color:#2F92EE;'>#α-1抗胰蛋白酶#</a>, objectTitle=J Hepatol：非硬化群體中患有α-1抗胰蛋白酶缺乏癥的成人的臨床和組織學(xué)特征, objectType=article, longId=147742, objectId=751514e7424a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=751514e7424a, replyNumber=0, likeNumber=117, createdTime=2019-03-18, rootId=0, userName=ms7514935887898259, userId=78d82500042, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=751514e7424a, moduleTitle=J Hepatol：非硬化群體中患有α-1抗胰蛋白酶缺乏癥的成人的臨床和組織學(xué)特征, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=751514e7424a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
